siRNA useful in the treatment of flavivirus infection
US9328347B2 · kind B2 · utility
2Cited by
0References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2012 |
| Grant date | May 3, 2016 |
| Priority date | — |
| Expiry date | Oct 13, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/24111
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions that comprise an siRNA molecule used in the treatment of diseases caused by flavivirus infection and methods of their use are disclosed. The pharmaceutical compositions treat diseases caused by yellow fever virus, West Nile virus, and dengue virus and include a single pharmaceutical composition active against all four dengue virus serotypes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.